April 24, 2014 5:49 AM ET


Company Overview of Ascenta Therapeutics, Inc.

Company Overview

Ascenta Therapeutics, Inc., a biopharmaceutical company, discovers and develops medicines for the treatment of cancer. Its technology consists of agents designed to re-establish the program of apoptosis (cell death) in abnormal cancer cells. The company’s products include AT-101, a pan Bcl-2 inhibitor that directly induces apoptosis by operating as a BH3 mimetic and indirectly as a p53-independent upregulator of Noxa and Puma; AT-406, a multi-inhibitor of apoptosis protein (IAP) antagonist that promotes programmed cell death (apoptosis) in tumor cells by blocking the activity of inhibitors of apoptosis proteins or IAPs, including XIAP, c-IAP1, c-IAP2, and ML-IAP to create conditions in which...

101 Lindenwood Drive

Suite 405

Malvern, PA 19355

United States

Founded in 2003





Key Executives for Ascenta Therapeutics, Inc.

Chief Executive Officer
Age: 56
Co-Founder and Director
Age: 68
Chief Financial Officer
Age: 64
Chief Medical Officer and Vice President of Clinical Development
Compensation as of Fiscal Year 2013.

Similar Private Companies By Industry

Company Name Region
Penwest Pharmaceuticals Co. United States
Liviam Nutraceuticals, LLC United States
Medique Products Inc. United States
Akorn-Strides, LLC United States
Revogenex, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ascenta Therapeutics, Inc., please visit www.ascenta.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.